Table of Contents

company-logo

Concord Biotech Limited, a biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally. It provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. The company also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus for immunosuppressants therapeutic segment; temsirolimus, everolimus, romidepsin, mitomycin, midostaurin, and dactinomycin for oncology therapeutic segment; mupirocin, mupirocin calcium, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, and micafungin sodium for anti-fungal therapeutic segment; and lovastatin and pravastatin sodium for other applications. In addition, it provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.

Concord Biotech Dividend Announcement

• Concord Biotech announced a annually dividend of ₹8.75 per ordinary share which will be made payable on 2024-07-29. Ex dividend date: 2024-06-21
• Concord Biotech annual dividend for 2024 was ₹8.75
• Concord Biotech's trailing twelve-month (TTM) dividend yield is 0.42%

Concord Biotech Dividend History

Ex-Div dateDividend amountDividend typePay date
2024-06-21₹8.75annually2024-07-29

Concord Biotech Dividend per year

Concord Biotech Dividend Yield

Concord Biotech current trailing twelve-month (TTM) dividend yield is 0.42%. Interested in purchasing Concord Biotech stock? Use our calculator to estimate your expected dividend yield:

Concord Biotech Financial Ratios

P/E ratio65.75
PEG ratio0.61
P/B ratio13.56
ROE21.87%
Payout ratio0.00%
Current ratio6.60
Quick ratio4.83
Cash Ratio0.05

Concord Biotech Dividend FAQ

Does Concord Biotech stock pay dividends?
Concord Biotech does not currently pay dividends to its shareholders.
Has Concord Biotech ever paid a dividend?
No, Concord Biotech has no a history of paying dividends to its shareholders. Concord Biotech is not known for its dividend payments.
Why doesn't Concord Biotech pay dividends?
There are several potential reasons why Concord Biotech would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Concord Biotech ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Concord Biotech has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Concord Biotech a dividend aristocrat?
Concord Biotech is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Concord Biotech a dividend king?
Concord Biotech is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Concord Biotech a dividend stock?
No, Concord Biotech is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Concord Biotech stocks?
To buy Concord Biotech you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Concord Biotech stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.